Login:
 
Savill P. New antiplatelet agents are more effective in preventing recurrent MI. Practitioner Oct 2018;262(1819):7

New antiplatelet agents are more effective in preventing recurrent MI

22 Oct 2018Registered users

Compared with clopidogrel, prasugrel and, in particular ticagrelor, led to a significant reduction in risk of recurrent fatal and non-fatal myocardial infarction (MI) in patients with acute coronary syndrome (ACS), in a study from France.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.

To buy this article (£25+tax) copy the article citation above and click Buy article